Randy Milby - Jan 1, 2023 Form 4/A - Amendment Insider Report for Hillstream BioPharma Inc. (HILS)

Signature
/s/ Randy Milby
Stock symbol
HILS
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
3/13/2023, 04:17 PM
Date Of Original Report
Jan 4, 2023
Previous filing
Jun 21, 2022
Next filing
Dec 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HILS Options (right to purchase) Award $0 +515K $0.00 515K Jan 1, 2023 Common stock 515K $0.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Issuer's 2019 Stock Incentive Plan and vested in full upon grant.

Remarks:

This Form 4 is filed to amend the Form 4 filed by the Reporting Person on January 4, 2023 (the "Original Form 4"). The Original Form 4 is hereby amended to reflect that the Reporting Person should have received options to purchase 515,127 shares of the Issuer's common stock as there were only 515,127 shares of the Issuer's common stock available for issuance under the Issuer's 2019 Stock Incentive Plan on the date of grant.